Enforcement of biologics in Europe under the UPC

4^th International Conference and Exhibition on Biologics & Biosimilars

October 26-28, 2015 Baltimore, USA

Willem A Hoyng

Hoyng Monegier, The Netherlands

Posters-Accepted Abstracts: J Bioanal Biomed

Abstract :

During 2016 the UP and UPC will come into force in Europe. This means that patentees have to make (tough and difficult) choices in how to protect their inventions in Europe by national patents, European patents and/or Unitary Patents. The Unified Patent Court will change not only the landscape of enforcement and litigation but will also influence the material patent law of Europe in for Biologics and Biosimilars important fields such as the scope of protection and more especially the doctrine of equivalence.

Biography :

Email: